Literature DB >> 26895832

Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation.

Kelsey E Huus1, Julie Joseph2, Li Zhang2, Alex Wong3, Shawn D Aaron4, Thien-Fah Mah2, Subash Sad5.   

Abstract

Immune recognition of pathogen-associated ligands leads to assembly and activation of inflammasomes, resulting in the secretion of inflammatory cytokines IL-1β and IL-18 and an inflammatory cell death called pyroptosis. Inflammasomes are important for protection against many pathogens, but their role during chronic infectious disease is poorly understood. Pseudomonas aeruginosa is an opportunistic pathogen that persists in the lungs of cystic fibrosis (CF) patients and may be responsible for the repeated episodes of pulmonary exacerbation characteristic of CF. P. aeruginosa is capable of inducing potent inflammasome activation during acute infection. We hypothesized that to persist within the host during chronic infection, P. aeruginosa must evade inflammasome activation, and pulmonary exacerbations may be the result of restoration of inflammasome activation. We therefore isolated P. aeruginosa from chronically infected CF patients during stable infection and exacerbation and evaluated the impact of these isolates on inflammasome activation in macrophages and neutrophils. P. aeruginosa isolates from CF patients failed to induce inflammasome activation, as measured by the secretion of IL-1β and IL-18 and by pyroptotic cell death, during both stable infection and exacerbation. Inflammasome evasion likely was due to reduced expression of inflammasome ligands and reduced motility and was not observed in environmental isolates or isolates from acute, non-CF infection. These results reveal a novel mechanism of pathogen adaptation by P. aeruginosa to avoid detection by inflammasomes in CF patients and indicate that P. aeruginosa-activated inflammasomes are not involved in CF pulmonary exacerbations.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26895832     DOI: 10.4049/jimmunol.1501642

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Pseudomonas aeruginosa and Klebsiella pneumoniae Adaptation to Innate Immune Clearance Mechanisms in the Lung.

Authors:  Sebastian A Riquelme; Danielle Ahn; Alice Prince
Journal:  J Innate Immun       Date:  2018-04-04       Impact factor: 7.349

2.  Potentiation of Aminoglycoside Lethality by C4-Dicarboxylates Requires RpoN in Antibiotic-Tolerant Pseudomonas aeruginosa.

Authors:  Clayton W Hall; Eszter Farkas; Li Zhang; Thien-Fah Mah
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

3.  Inflammasome Genetic Variants, Macrophage Function, and Clinical Outcomes in Cystic Fibrosis.

Authors:  Andrew D Graustein; William R Berrington; Kati J Buckingham; Felicia K Nguyen; Lara L Joudeh; Margaret Rosenfeld; Michael J Bamshad; Ronald L Gibson; Thomas R Hawn; Mary J Emond
Journal:  Am J Respir Cell Mol Biol       Date:  2021-08       Impact factor: 6.914

4.  Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response.

Authors:  Melissa S Phuong; Rafael E Hernandez; Daniel J Wolter; Lucas R Hoffman; Subash Sad
Journal:  Cell Death Dis       Date:  2021-03-04       Impact factor: 8.469

Review 5.  Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?

Authors:  Emmanuel Faure; Kelly Kwong; Dao Nguyen
Journal:  Front Immunol       Date:  2018-10-22       Impact factor: 7.561

6.  Guanylate binding proteins facilitate caspase-11-dependent pyroptosis in response to type 3 secretion system-negative Pseudomonas aeruginosa.

Authors:  Arjun Balakrishnan; Rajendra Karki; Brent Berwin; Masahiro Yamamoto; Thirumala-Devi Kanneganti
Journal:  Cell Death Discov       Date:  2018-06-27

Review 7.  Hot topics and current controversies in non-cystic fibrosis bronchiectasis.

Authors:  Diego Severiche-Bueno; Enrique Gamboa; Luis F Reyes; Sanjay H Chotirmall
Journal:  Breathe (Sheff)       Date:  2019-12

8.  Molecular characterization of the pilS2 gene and its association with the frequency of Pseudomonas aeruginosa plasmid pKLC102 and PAPI-1 pathogenicity island.

Authors:  Aghil Bahramian; Saeed Khoshnood; Aref Shariati; Farahnoosh Doustdar; Alireza Salimi Chirani; Mohsen Heidary
Journal:  Infect Drug Resist       Date:  2019-01-11       Impact factor: 4.003

Review 9.  Out-Smarting the Host: Bacteria Maneuvering the Immune Response to Favor Their Survival.

Authors:  Nastaran Mues; Hong Wei Chu
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 8.786

Review 10.  Pulmonary Pathogens Adapt to Immune Signaling Metabolites in the Airway.

Authors:  Sebastián A Riquelme; Tania Wong Fok Lung; Alice Prince
Journal:  Front Immunol       Date:  2020-03-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.